Geneos Wealth Management’s Sabre SABR Stock Holding History

Geneos Wealth Management’s Portfolio SABR Stock Details SABR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-358	Closed	-$866	–	2162
2024 Q1	$866	Buy	+358	New	+$1.2K	﹤0.01%	2055
2022 Q3	–	Sell	-100	Closed	–	–	2482
2022 Q2	$0	Hold	100	–	–	﹤0.01%	2760
2022 Q1	$1K	Buy	+100	New	+$980	﹤0.01%	2686
2021 Q4	–	Sell	-100	Closed	-$1K	–	2861
2021 Q3	$1K	Hold	100	–	–	﹤0.01%	2780
2021 Q2	$1K	Sell	100 -50	-33%	-$703	﹤0.01%	2792
2021 Q1	$2K	Buy	150 +50	+50%	+$678	﹤0.01%	2924
2020 Q4	$1K	Buy	+100	New	+$925	﹤0.01%	2824
2020 Q3	–	Sell	-164	Closed	-$1K	–	2684
2020 Q2	$1K	Buy	+164	New	+$1.16K	﹤0.01%	2500
2020 Q1	–	Sell	-64	Closed	-$1K	–	2588
2019 Q4	$1K	Hold	64	–	–	﹤0.01%	2494
2019 Q3	$1K	Hold	64	–	–	﹤0.01%	2431
2019 Q2	$1K	Buy	+64	New	+$1.37K	﹤0.01%	2436

Other funds holding SABR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Discerene Group Stamford, Connecticut $946M AUM 1.38% 1-Year Est. Return

AMH

Apollo Management Holdings New York $7.6B AUM 23.97% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OHA

Oak Hill Advisors New York $878M AUM 106.46% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

Geneos Wealth Management's SABR Position: Q2 2024 in Review

Geneos Wealth Management sold out of Sabre (SABR) in Q2 2024, closing a stake of 358 shares — an estimated $866 sold.

Geneos Wealth Management first reported a position in SABR in Q2 2019 and held it in 11 quarters. The position peaked at $2K in Q1 2021. 241 funds tracked by Wall St. Rank hold SABR as of Q2 2024.

Geneos Wealth Management reported no remaining Sabre position as of Q2 2024 after selling out during the quarter.
Geneos Wealth Management sold 358 Sabre shares in Q2 2024, an estimated $866.
Geneos Wealth Management first reported a position in Sabre in Q2 2019 and held it in 11 quarters.
Geneos Wealth Management's Sabre position peaked at $2K in Q1 2021.
241 funds tracked by Wall St. Rank held Sabre as of Q2 2024.

Based on Geneos Wealth Management's 13F filing for Q2 2024, filed 23 Jul 2024.